CD123-targeted CAR-NK therapy

CAR-NK cells targeting CD123 · Chongqing Precision Biotech Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD123-targeted CAR-NK therapy, covering 2024-11-15 to 2024-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/refractory AML or BPDCN [Phase 1]